IL142069A0 - Methods of downmodulating the immune response to therapeutic proteins - Google Patents

Methods of downmodulating the immune response to therapeutic proteins

Info

Publication number
IL142069A0
IL142069A0 IL14206999A IL14206999A IL142069A0 IL 142069 A0 IL142069 A0 IL 142069A0 IL 14206999 A IL14206999 A IL 14206999A IL 14206999 A IL14206999 A IL 14206999A IL 142069 A0 IL142069 A0 IL 142069A0
Authority
IL
Israel
Prior art keywords
downmodulating
methods
immune response
therapeutic proteins
proteins
Prior art date
Application number
IL14206999A
Other languages
English (en)
Original Assignee
Genetics Inst
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, American Nat Red Cross filed Critical Genetics Inst
Publication of IL142069A0 publication Critical patent/IL142069A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14206999A 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins IL142069A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15817898A 1998-09-21 1998-09-21
PCT/US1999/021991 WO2000016801A1 (fr) 1998-09-21 1999-09-21 Methodes de modulation restrictive de la reponse immunitaire aux proteines therapeutiques

Publications (1)

Publication Number Publication Date
IL142069A0 true IL142069A0 (en) 2002-03-10

Family

ID=22566971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14206999A IL142069A0 (en) 1998-09-21 1999-09-21 Methods of downmodulating the immune response to therapeutic proteins

Country Status (21)

Country Link
EP (1) EP1115423A1 (fr)
JP (1) JP2002526455A (fr)
KR (1) KR20010085830A (fr)
CN (1) CN1331602A (fr)
AU (1) AU761206B2 (fr)
BR (1) BR9913991A (fr)
CA (1) CA2343916A1 (fr)
CZ (1) CZ20011021A3 (fr)
EA (1) EA005236B1 (fr)
HK (1) HK1039059A1 (fr)
HU (1) HUP0103960A3 (fr)
IL (1) IL142069A0 (fr)
LT (1) LT4920B (fr)
LV (1) LV12768B (fr)
MX (1) MXPA01002898A (fr)
NO (1) NO20011412L (fr)
NZ (1) NZ511034A (fr)
PL (1) PL346796A1 (fr)
SI (1) SI20626A (fr)
WO (1) WO2000016801A1 (fr)
ZA (1) ZA200103156B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US20020031508A1 (en) * 2000-05-19 2002-03-14 Wagner Denisa D. Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity
EP1636579A4 (fr) * 2003-06-10 2011-10-05 Smiths Detection Inc Ensemble detecteur
GB201508024D0 (en) * 2015-05-11 2015-06-24 Haemostatix Ltd Haemostatic compositions

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171569A (en) 1985-03-15 1992-12-15 National Research Development Corporation Factor IX preparations uncontaminated by plasma components or pox virus
ES8801674A1 (es) 1985-04-12 1988-02-16 Genetics Inst Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
FR2657884B1 (fr) 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
US5770197A (en) 1991-06-27 1998-06-23 Bristol-Myers Squibb Company Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
CA2580812A1 (fr) 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Recepteur ctla, proteines hybrides qui le contiennent et ses applications
WO1993009804A1 (fr) 1991-11-18 1993-05-27 The Scripps Research Institute Polypeptides derives de la serine protease et anticorps anti-peptidiques, systemes et procedes therapeutiques empechant la coagulation du sang
US5744446A (en) 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5364771A (en) 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US5663060A (en) 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
EP0776217A1 (fr) * 1994-08-19 1997-06-04 Novo Nordisk A/S Methode de traitement d'un patient a l'aide d'un compose biologiquement actif
EP0804076A4 (fr) * 1994-10-19 1998-10-21 Genetic Therapy Inc Therapie genique par administration concurrente et repetee d'adenovirus et d'agents immunodepresseurs
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
ATE219376T1 (de) * 1996-03-20 2002-07-15 Bristol Myers Squibb Co Verfahren zur inhibierung der immunreaktion durch blockierung der gp39/cd40 und ctla4/cd28/b7 routen und zusammensetzung zu deren verwendung
JP2001508450A (ja) * 1997-01-10 2001-06-26 バイオジェン インコーポレイテッド 抗ｃｄ４０ｌ化合物の治療学的投与の方法
JP2002504910A (ja) * 1997-06-20 2002-02-12 バイオジェン，インコーポレイテッド 治療用タンパク質阻害因子症候群のためのｃｄ１５４遮断治療
US8112896B2 (en) 2009-11-06 2012-02-14 Hexagon Metrology Ab Articulated arm

Also Published As

Publication number Publication date
CN1331602A (zh) 2002-01-16
SI20626A (sl) 2002-02-28
NO20011412L (no) 2001-05-16
EA200100385A1 (ru) 2001-10-22
MXPA01002898A (es) 2002-06-04
EP1115423A1 (fr) 2001-07-18
HUP0103960A2 (hu) 2002-02-28
WO2000016801A1 (fr) 2000-03-30
NO20011412D0 (no) 2001-03-20
HK1039059A1 (zh) 2002-04-12
AU6057899A (en) 2000-04-10
LT2001045A (en) 2002-01-25
NZ511034A (en) 2004-03-26
BR9913991A (pt) 2001-07-03
CZ20011021A3 (cs) 2001-10-17
JP2002526455A (ja) 2002-08-20
EA005236B1 (ru) 2004-12-30
HUP0103960A3 (en) 2003-09-29
PL346796A1 (en) 2002-02-25
ZA200103156B (en) 2002-07-18
CA2343916A1 (fr) 2000-03-30
LT4920B (lt) 2002-06-25
LV12768A (en) 2001-12-20
LV12768B (lv) 2002-06-20
KR20010085830A (ko) 2001-09-07
AU761206B2 (en) 2003-05-29
WO2000016801A9 (fr) 2000-10-26

Similar Documents

Publication Publication Date Title
AP2000001983A0 (en) Antibodies to cd23 derivatives thereof and their therapeutic uses
IL132318A0 (en) Substituted imidazoles useful in the treatment of inflammatory diseases
ID28111A (id) Metoda untuk meningkatkan kesehatan kulit
IL135673A0 (en) Therapeutic uses of quinoline derivatives
EP1033994A4 (fr) Methodes de preparation de bioginko
FI964193A (fi) Puriinien valmistaminen
HK1026096A1 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
ZA984177B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9930443D0 (en) Novel use of heat shock proteins
HUP0103960A3 (en) Methods of downmodulating the immune response to therapeutic proteins
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
FI953580A (fi) Asyklovirin valmistus
ID24759A (id) Metoda untuk meningkatkan volume tulang
GB9822619D0 (en) Immune response stimulation
GB9727410D0 (en) Improvements relating to adjustable furniture
GB9727230D0 (en) Improvements relating to adjustable furniture
KR960025637U (ko) 간격조절이 용이한 콘넥터
NO965332D0 (no) Terapeutisk perparat
GB9720509D0 (en) Improvements relating to furniture
TW315720U (en) Structure of treadmill also having the resupination function of human body
KR960013110U (ko) 신발의 바닥면에 착탈이 용이한 지압구
TW322782U (en) Structure improvement of walker
TW351186U (en) Improvement of exercise walker
TW369896U (en) Modified walker structure
FI971745A (fi) Selkärangan dynaaminen malli